查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577505

全球醫療資訊市場

Medical Information
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球醫療資訊市場預計將達到 41 億美元

全球醫療資訊市場預計 2023 年為 28 億美元，預計到 2030 年將達到 41 億美元，2023 年至 2030 年複合年成長率為 5.4%。內部服務是本報告分析的細分市場之一，預計複合年成長率為 5.0%，到分析期結束時將達到 23 億美元。分析期間內，合約外包服務分部的複合年成長率預計為 5.9%。

美國市場預估價值7.666億美元，中國預期複合年成長率為8.6%

預計 2023 年美國醫療資訊市場規模將達到 7.666 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達8.439億美元，2023-2030年分析期間複合年成長率為8.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.2% 和 5.5%。在歐洲，德國的複合年成長率預計為 3.3%。

全球醫療資訊市場 - 主要趨勢和促進因素總結

醫療資訊是如何演變的？

在過去的幾十年裡，醫療資訊經歷了巨大的轉變，從保存在文件櫃中的紙本記錄發展到可以在世界任何地方即時存取的先進電子健康記錄(EHR)。過去，醫療保健提供者之間共用患者資料通常既耗時又低效，導致護理分散。然而，隨著數位解決方案的出現，醫療資訊變得更加簡化和易於訪問，從而提高了醫療保健的整體品質。這種轉變是由對更好的患者治療結果、資料安全和監管合規性的日益成長的需求所推動的。此外，醫療保健提供者和患者都在採用行動醫療(行動醫療) 應用、穿戴式裝置和遠端醫療來遠端監控和管理他們的健康狀況。這些進步帶來了更個人化的治療，資料在根據患者個別需求客製化治療方面發揮關鍵作用。這一演變凸顯了科技在彌合患者和醫療保健提供者之間的差距方面變得多麼重要。

當今醫療資訊面臨哪些道德和隱私挑戰？

儘管數位健康資訊具有不可否認的好處，但對資料隱私和安全的重大擔憂仍然存在。網路攻擊和資料外洩的增加使患者和醫療保健提供者面臨敏感醫療資訊落入壞人之手的可能性。最緊迫的道德問題之一涉及資料共用和患者保密之間的平衡。隨著越來越多的資料透過網路共用以促進協作護理和研究，需要確保正確獲得患者同意並確保患者資料的安全。美國的《健康保險互通性與課責法案》(HIPAA) 和歐洲的《一般資料保護規範》(GDPR) 等法律規範為如何處理健康資料製定了嚴格的準則。然而，這些法規因地區而異，因此很難制定醫療資訊安全的全球標準。此外，使用人工智慧（AI）和機器學習演算法來分析醫療資料引發了關於決策中潛在偏見和這些系統透明度的爭論。隨著科技的不斷發展，解決這些道德和隱私挑戰對於維持對醫療保健系統的信任至關重要。

科技在改變健康資訊的取得方面將發揮什麼作用？

科技處於改變健康資訊取得、共用和使用方式的最前線。巨量資料分析的興起使醫療保健提供者能夠分析大量醫療資料以檢測模式並預測健康狀況。雲端處理整合使醫療保健組織能夠安全地儲存和存取醫療記錄，同時降低與本地儲存系統相關的成本。此外，遠端醫療平台和患者門戶網站使患者能夠更好地控制自己的健康狀況，使他們能夠存取醫療記錄、與醫療保健提供者溝通，甚至在線上安排預約。人工智慧在診斷工具中的使用也提高了診斷的準確性和速度，減少了人為錯誤的可能性，並使醫療保健提供者能夠做出更明智的決策。智慧型手錶和健身追蹤器等穿戴式裝置可以持續監測患者的生命徵象，從而及早發現健康問題並更及時地進行干預。隨著醫療保健系統變得數位化，技術無疑將在提高醫療資訊的可及性和品質方面發揮更大的作用。

推動醫療資訊市場成長的因素有哪些？

醫療資訊市場的成長是由多種因素推動的，其中許多因素與技術進步和消費行為的變化直接相關。首先，世界各地的醫療機構擴大採用 EHR 系統，這推動了對可靠且擴充性的數位解決方案的需求。不同系統之間的互通性需求也是一個關鍵促進因素，因為醫療保健提供者尋求一種無縫的方式共用患者資訊。此外，慢性病盛行率的增加需要更頻繁和更全面的病患監測，導致遠端監測設備和行動醫療應用的需求激增。消費者行為也在發生變化，患者越來越期望獲得更便利、數位化優先的醫療保健體驗。這促使遠端醫療服務快速成長。政府促進數位健康的措施以及醫療保健領域資料主導決策的需求也促進了市場的擴張。最後，人工智慧和機器學習與醫療資訊系統的整合正在透過提高預測分析和診斷準確性來推動市場成長，並為醫療保健提供者提供尖端工具以更有效地管理患者資料。

受訪企業範例（36家知名企業）

  • Accenture Plc
  • Cognizant Technology Solutions US Corporation
  • Eversana
  • Groupe ProductLife SAS
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP24030

Global Medical Information Market to Reach US$4.1 Billion by 2030

The global market for Medical Information estimated at US$2.8 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. In-House Services, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Contract Outsourcing Services segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$766.6 Million While China is Forecast to Grow at 8.6% CAGR

The Medical Information market in the U.S. is estimated at US$766.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$843.9 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Medical Information Market - Key Trends and Drivers Summarized

How Has Medical Information Evolved Over Time?

Medical information has undergone a dramatic transformation over the last few decades, evolving from paper-based records maintained in filing cabinets to sophisticated electronic health records (EHRs) that can be accessed in real-time from anywhere in the world. In the past, the sharing of patient data between healthcare providers was often slow and inefficient, leading to fragmented care. However, with the advent of digital solutions, medical information is now more streamlined and accessible, enhancing the overall quality of healthcare. This shift has been driven by the increasing demand for better patient outcomes, data security, and regulatory compliance. In addition, healthcare providers and patients alike are now embracing mobile health (mHealth) applications, wearables, and telemedicine to monitor and manage health conditions remotely. These advancements have resulted in more personalized care, with data playing a crucial role in tailoring treatments to individual patients' needs, thus moving the medical landscape toward more proactive and preventive care approaches. This evolution highlights how crucial technology has become in bridging the gap between patients and healthcare providers.

What Are the Ethical and Privacy Challenges Facing Medical Information Today?

Despite the undeniable benefits of digital medical information, significant concerns about data privacy and security persist. The rise of cyber-attacks and data breaches has left both patients and healthcare providers vulnerable to the potential misuse of sensitive medical information. One of the most pressing ethical issues involves the balance between data sharing and patient confidentiality. As more data is shared across networks to facilitate collaborative care and research, there is a growing need to ensure that patient consent is properly obtained, and their data remains secure. Regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe, have set strict guidelines on how medical data should be handled. However, these regulations vary significantly across regions, making it difficult to create a global standard for medical information security. Additionally, the use of artificial intelligence (AI) and machine learning algorithms to analyze medical data has sparked debates about potential biases in decision-making and the transparency of these systems. As technology continues to evolve, addressing these ethical and privacy challenges will be paramount to maintaining trust in the healthcare system.

What Role Does Technology Play in Transforming Access to Medical Information?

Technology is at the forefront of revolutionizing how medical information is accessed, shared, and utilized. The rise of big data analytics has enabled healthcare providers to analyze vast amounts of medical data to detect patterns and predict health outcomes, thus improving the overall efficiency of the healthcare system. The integration of cloud computing has further enabled healthcare organizations to store and access medical records securely while reducing the costs associated with on-premise storage systems. Furthermore, telemedicine platforms and patient portals have empowered patients to take more control of their health, allowing them to access their medical records, communicate with their healthcare providers, and even schedule appointments online. The use of AI in diagnostic tools is also enhancing the accuracy and speed of diagnosis, reducing the chances of human error and enabling healthcare providers to make more informed decisions. Wearable devices, such as smartwatches and fitness trackers, are allowing for continuous monitoring of patients’ vital signs, leading to early detection of health issues and more timely interventions. As the healthcare system continues to digitize, technology will undoubtedly play an even greater role in improving both the accessibility and quality of medical information.

What Are the Growth Drivers in the Medical Information Market?

The growth in the medical information market is driven by several factors, many of which are directly linked to technological advancements and changing consumer behavior. First, the increasing adoption of EHR systems across healthcare facilities worldwide has created a massive demand for reliable and scalable digital solutions. The need for interoperability between different systems is another key driver, as healthcare providers seek seamless ways to share patient information across multiple platforms and institutions. Additionally, the growing prevalence of chronic diseases has necessitated more frequent and comprehensive patient monitoring, leading to a surge in demand for remote monitoring devices and mHealth applications. Consumer behavior has also shifted, with patients increasingly expecting more convenient, digital-first healthcare experiences. This has driven the rapid growth of telemedicine services. Government initiatives promoting digital health and the need for data-driven decision-making in healthcare are also contributing to the expansion of the market. Lastly, the integration of AI and machine learning into medical information systems is enhancing predictive analytics and diagnostic accuracy, further fueling market growth by providing healthcare providers with cutting-edge tools to manage patient data more effectively.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Medical Information - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Timely Healthcare Data Propels Growth in the Medical Information Market
    • Increasing Focus on Patient-Centered Care Expands Addressable Market for Personalized Medical Information Solutions
    • Technological Advancements in Electronic Health Records (EHR) Drive Innovation in Medical Information Systems
    • Growing Use of AI and Machine Learning in Data Analysis Strengthens the Business Case for Medical Information Management
    • Rising Adoption of Telemedicine and Digital Health Platforms Spurs Demand for Real-Time Medical Information Access
    • Increasing Use of Mobile Health (mHealth) Apps Propels Growth in Consumer Access to Medical Information
    • Innovations in Blockchain for Secure Data Sharing Drive Trust in Medical Information Platforms
    • Here's How the Expansion of Health Information Exchanges (HIEs) Accelerates the Interoperability of Medical Information Systems
    • Surging Demand for Clinical Decision Support Systems (CDSS) Drives Growth in Medical Information Integration
    • Advancements in Wearable Devices and IoT Propel Growth in the Real-Time Medical Information Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Information Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Contract Outsourcing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Medical Device Manufacturers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION